• Home
• alpha prime
• AlphaPrime: Using AI to turbocharge clinical trial processes

AlphaPrime: Using AI to turbocharge clinical trial processes

4.5 (562) · $ 14.50 · In stock

Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s

How AI and Automation Transforming Clinical Trials

Post page · Page 149 of 1608 · TechNode

AlphaPrime - Crunchbase Company Profile & Funding

AI can boost clinical trials in 2024. 5 ways it could boost

Benson Hao posted on LinkedIn

Regulations to enable Safe, Effective & high-Quality AI/ML/Digital

Alice Hsu on LinkedIn: Thank you Microsoft & HLTH 2023 at Las Vegas!!!

Benson Hao on LinkedIn: Happy Chinese New Year! Give my best

Harbour BioMed Reports the Latest Progress from Phase I Clinical

Premier PINC AI™ Data: Three Must-Know Capabilities

News - AlphaPrime

TCER® IMA402